Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology

Results of this economic evaluation suggest that specialty medications have become a substantial factor in dermatology drug spending. While the price of the average dermatologic medication has increased rapidly, this primarily reflects increased prescribing of newly introduced specialty drugs. While these therapies expand treatment options, their rising share of costs highlights the need for policies that balance innovation, access, and affordability.